AACR Annual Meeting 2021 - Biognosys

AACR Annual Meeting 2021

 

At this year’s AACR Virtual Annual Meeting, Biognosys is proud to present a minisymposium, highlighting our work with AstraZeneca and ETH Zurich on the use of a novel chemoproteomic approach to drug target identification, and three posters:

Biognosys' Presentations at the Virtual AACR Annual Conference 2021

Resource - Case Studies
LiP-MS, A Machine Learning-based Chemoproteomic Approach to Identify Drug Targets in Complex Proteomes

Slide Deck from Minisymposium #21 at AACR 2021 Presenter: Nigel Beaton A collaboration with:  AstraZeneca, ETH[...]

READ MORE
Resource - Case Studies
Dissection of Drug-Protein Interactions by HR-LiP-MS in Target Validation and Lead Optimization

E-poster #298 presented at AACR 2021 Presenter: Yuehan Feng A collaboration with:  Cedilla Therapeutics E-poster[...]

READ MORE
Resource - Case Studies
Immune-related Adverse Effects (irAEs) Associated Proteomic Profile in Late-stage NSCLC Patients after PD-1 Blockade

E-poster #1615 presented at AACR 2021 Presenter: Kamil Sklodowski A collaboration with: Institut Curie, Paris, France; San Luigi Gonzaga[...]

READ MORE
Resource - Case Studies
Response and Skin Toxicity Related Protein Signature in Late Stage Melanoma Patients after Anti-PD-1 Treatment

E-poster #1623 presented at AACR 2021 Presenter: Kamil Sklodowski A collaboration with: Instituto Nazionale Tumori IRCCS Fondazione Pascale,[...]

READ MORE

Visit our Virtual Booth

 

Book a Personal Poster Presentation

 

Request a Consultation to Accelerate your Research

Contact

    By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More